Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed360%
unknown240%

Recent Activity

0 active trials
Showing 5 of 5
unknownnot_applicable

HOPE to Reduce Tumour Recurrence After LT In Patients With HCC

NCT05876052
unknownnot_applicable

Hypothermic Oxygenated (HOPE) Versus Normothermic Machine Perfusion (NMP) in Human Liver Transplantation

NCT04644744
completednot_applicable

Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts

NCT01317342
completednot_applicable

HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts

NCT03124641
completednot_applicable

Interest of Oxygenated Hypothermic Perfusion (PHO) in Preservation of Hepatic Grafts From Expanded Criteria Donors

NCT03376074

Clinical Trials (5)

Showing 5 of 5 trials
NCT05876052Not Applicable

HOPE to Reduce Tumour Recurrence After LT In Patients With HCC

Unknown
NCT04644744Not Applicable

Hypothermic Oxygenated (HOPE) Versus Normothermic Machine Perfusion (NMP) in Human Liver Transplantation

Unknown
NCT01317342Not Applicable

Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts

Completed
NCT03124641Not Applicable

HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts

Completed
NCT03376074Not Applicable

Interest of Oxygenated Hypothermic Perfusion (PHO) in Preservation of Hepatic Grafts From Expanded Criteria Donors

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5